Oral contraceptive use and the risk of breast cancer

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The clinical impact of the association between oral contraceptive (OC) use and breast cancer risk is important given that OCs are the most commonly prescribed contraceptive agent and that more than a quarter of a million women are diagnosed as having breast cancer in the United States annually. Substantial changes to OC formulations have been made during the past decade, and this review focuses on recent OC trends and risks and benefits. We also have a better understanding of how estrogen affects breast carcinogenesis; research on this topic is ongoing and has the goal of decreasing breast cancer incidence and mortality.

Original languageEnglish (US)
Pages (from-to)86-91
Number of pages6
JournalMayo Clinic Proceedings
Volume83
Issue number1
DOIs
StatePublished - 2008

Fingerprint

Oral Contraceptives
Breast Neoplasms
Contraceptive Agents
Estrogens
Carcinogenesis
Breast
Mortality
Incidence
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Oral contraceptive use and the risk of breast cancer. / Casey, Petra Marcela; Cerhan, James R; Pruthi, Sandhya.

In: Mayo Clinic Proceedings, Vol. 83, No. 1, 2008, p. 86-91.

Research output: Contribution to journalArticle

@article{1d6b1cd12d2f4a9bbc51f7041eb2b169,
title = "Oral contraceptive use and the risk of breast cancer",
abstract = "The clinical impact of the association between oral contraceptive (OC) use and breast cancer risk is important given that OCs are the most commonly prescribed contraceptive agent and that more than a quarter of a million women are diagnosed as having breast cancer in the United States annually. Substantial changes to OC formulations have been made during the past decade, and this review focuses on recent OC trends and risks and benefits. We also have a better understanding of how estrogen affects breast carcinogenesis; research on this topic is ongoing and has the goal of decreasing breast cancer incidence and mortality.",
author = "Casey, {Petra Marcela} and Cerhan, {James R} and Sandhya Pruthi",
year = "2008",
doi = "10.4065/83.1.86",
language = "English (US)",
volume = "83",
pages = "86--91",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "1",

}

TY - JOUR

T1 - Oral contraceptive use and the risk of breast cancer

AU - Casey, Petra Marcela

AU - Cerhan, James R

AU - Pruthi, Sandhya

PY - 2008

Y1 - 2008

N2 - The clinical impact of the association between oral contraceptive (OC) use and breast cancer risk is important given that OCs are the most commonly prescribed contraceptive agent and that more than a quarter of a million women are diagnosed as having breast cancer in the United States annually. Substantial changes to OC formulations have been made during the past decade, and this review focuses on recent OC trends and risks and benefits. We also have a better understanding of how estrogen affects breast carcinogenesis; research on this topic is ongoing and has the goal of decreasing breast cancer incidence and mortality.

AB - The clinical impact of the association between oral contraceptive (OC) use and breast cancer risk is important given that OCs are the most commonly prescribed contraceptive agent and that more than a quarter of a million women are diagnosed as having breast cancer in the United States annually. Substantial changes to OC formulations have been made during the past decade, and this review focuses on recent OC trends and risks and benefits. We also have a better understanding of how estrogen affects breast carcinogenesis; research on this topic is ongoing and has the goal of decreasing breast cancer incidence and mortality.

UR - http://www.scopus.com/inward/record.url?scp=37549017282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549017282&partnerID=8YFLogxK

U2 - 10.4065/83.1.86

DO - 10.4065/83.1.86

M3 - Article

C2 - 18174010

AN - SCOPUS:37549017282

VL - 83

SP - 86

EP - 91

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 1

ER -